Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) EBITDA (2019 - 2025)

Intelligent Bio Solutions has reported EBITDA over the past 6 years, most recently at -$2.8 million for Q2 2024.

  • For Q2 2024, EBITDA fell 8.37% year-over-year to -$2.8 million; the TTM value through Jun 2024 reached -$10.3 million, up 1.49%, while the annual FY2024 figure was -$10.3 million, 1.45% up from the prior year.
  • EBITDA for Q2 2024 was -$2.8 million at Intelligent Bio Solutions, up from -$3.1 million in the prior quarter.
  • Over five years, EBITDA peaked at -$28824.0 in Q1 2020 and troughed at -$6.4 million in Q1 2023.
  • A 5-year average of -$2.1 million and a median of -$1.9 million in 2020 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: plummeted 11660.49% in 2021 and later skyrocketed 98.11% in 2022.
  • Year by year, EBITDA stood at -$2.0 million in 2020, then plummeted by 76.66% to -$3.5 million in 2021, then skyrocketed by 98.11% to -$65474.0 in 2022, then crashed by 2803.82% to -$1.9 million in 2023, then tumbled by 47.89% to -$2.8 million in 2024.
  • Business Quant data shows EBITDA for INBS at -$2.8 million in Q2 2024, -$3.1 million in Q1 2024, and -$1.9 million in Q4 2023.